Cat. No. 3027
Alternative Name: Methylenedioxymethamphetamine hydrochloride
Chemical Name: N,α,-Dimethyl-3,4-methylenedioxyphenethylamine hydrochloride
Biological ActivityHallucinogenic compound that inhibits 5-HT and dopamine uptake.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Certificate of Analysis / Safety Data Sheet
Iravani et al (2000) Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphe nucleus slices. Synapse 36 275. PMID: 10819905.
Boyle et al (2007) MDMA ("ecstasy") suppresses the innate IFN-γ response in vivo: a critical role for the anti-inflammatory cytokine IL-10. Eur.J.Pharmacol. 572 228. PMID: 17689526.
Fleckenstein et al (2007) New insights into the mechanism of action of amphetamines. Annu.Rev.Pharmacol.Toxicol. 47 681. PMID: 17209801.
If you know of a relevant citation for this product please let us know.
View Related Products by Target
Keywords: (±)-MDMA hydrochloride, supplier, inhibitors, 5-HT, dopamine, reuptake, hallucinogenic, Serotonin, Transporters, SERT, 5-Hydroxytryptamine, Monoamine, Neurotransmitter, DAT, Methylenedioxymethamphetamine, hydrochloride
Find multiple products by catalog number
New Products in this Area
Potent noradrenalin and dopamine uptake inhibitor. Antidepressant
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.